Basic science of osteoarthritis - Université de Lorraine Accéder directement au contenu
Article Dans Une Revue Journal of Experimental Orthopaedics Année : 2016

Basic science of osteoarthritis

Résumé

Osteoarthritis (OA) is a prevalent, disabling disorder of the joints that affects a large population worldwide and for which there is no definitive cure. This review provides critical insights into the basic knowledge on OA that may lead to innovative end efficient new therapeutic regimens. While degradation of the articular cartilage is the hallmark of OA, with altered interactions between chondrocytes and compounds of the extracellular matrix, the subchondral bone has been also described as a key component of the disease, involving specific pathomechanisms controlling its initiation and progression. The identification of such events (and thus of possible targets for therapy) has been made possible by the availability of a number of animal models that aim at reproducing the human pathology, in particular large models of high tibial osteotomy (HTO). From a therapeutic point of view, mesenchymal stem cells (MSCs) represent a promising option for the treatment of OA and may be used concomitantly with functional substitutes integrating scaffolds and drugs/growth factors in tissue engineering setups. Altogether, these advances in the fundamental and experimental knowledge on OA may allow for the generation of improved, adapted therapeutic regimens to treat human OA.
Fichier principal
Vignette du fichier
Barcelone_2016 JEXO ICL paper.pdf (2.62 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Loading...

Dates et versions

hal-01705047 , version 1 (09-02-2018)

Identifiants

Citer

Magali Cucchiarini, Laura de Girolamo, Giuseppe Filardo, J. Miguel Miguel Oliveira, Patrick Orth, et al.. Basic science of osteoarthritis. Journal of Experimental Orthopaedics, 2016, 3 (1), pp.22. ⟨10.1186/s40634-016-0060-6⟩. ⟨hal-01705047⟩
170 Consultations
124 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More